Article info
Original research
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer
- Correspondence to Dr Willemien van Driel, Department of Gynaecology, Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands; w.v.driel{at}nki.nl
Citation
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer
Publication history
- Received July 6, 2020
- Revision received September 14, 2020
- Accepted September 21, 2020
- First published October 12, 2020.
Article Versions
- You are currently viewing a Previous version of this article (12 October 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.